Spike Another API Approved for Marketing
Release time:
2023-05-04
Peak Pharmaceutical's Fluprost API submitted its API registration information to the Drug Evaluation Center (CDE) of the State Drug Administration in February 2021, which was accepted and started the technical review in March of that year, and received a notice of issuance at the end of the year. In May 2022, the pharmaceutical company submitted supplementary research materials to the Drug Examination Center, and at the same time sent samples to Zhejiang Food and Drug Inspection Institute for partial quality standard review after the supplementary research. In September 2022, the Drug Review Center initiated the technical review of supplementary research data, and the final review results were in line with the relevant national technical standards for the review of APIs and approved for sale in the domestic market.
Tasfluprost is a prostaglandin analog. It is a selective prostaglandin receptor agonist. It can reduce intraocular pressure by increasing the outflow of aqueous humor through the uveoscleral route. It is used to reduce the increase of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Including Peak Pharmaceuticals, there are currently only two companies that have approved the listing of the API in China. The successful listing of the raw material drug of He Fluoroprost enriches the products of Peak Pharmaceuticals and helps to further expand the business areas of the company's pharmaceutical sector. (Xu Chunliu)
More information
The company won the Taurus Award
On December 29, 2022, the "2022 High-quality Development Forum of listed companies and the 24th Golden Bull Award presentation ceremony of listed companies" jointly sponsored by China Securities News, Haikou Municipal Government and Haikou National High-tech Zone was held in Haikou. The list of Golden Bull Awards of listed companies was officially announced. With its outstanding performance, Jianfeng Group won the "2021 Golden Bull Most Investment Value Award".
2023
01-12
From December 11th to 12th, the 13th National Congress of the All-China Federation of Industry and Commerce was held in Beijing. Jiang Xiaomeng, chairman of the group company, attended the conference as a representative of Zhejiang.
2022
12-22
Yunnan Jianfeng won the title of "Harmonious Labor Relations Enterprise" in Yunnan Province
On November 18, the Yunnan Provincial Federation of Trade Unions, the Department of Human Resources and Social Security, the Entrepreneur Association and other units jointly issued a document to commend the harmonious labor relations enterprises in Yunnan Province from 2020 to 2021. Yunnan Jianfeng Cement Company is on the list and is the only enterprise in the urban area of Pu'er to receive this honor.
2022
12-13
Huang Ping Jianfeng won the title of "provincial green factory" in Guizhou
On November 30, the Guizhou Provincial Department of Industry and Information Technology released the 2022 list of green manufacturing units in Guizhou Province, and Huangping Jianfeng Cement Company was recognized as a "provincial green factory".
2022
12-13
On December 2, Yu Jianhong, general manager of the group company, gave a management lesson to the company's reserve management talents under the title of "Enterprise Management Innovation in Great Changes.
2022
12-13
On November 24, Jiang Xiaomeng, secretary of the party committee and chairman of the group company, gave a special party lesson to all party members and cadres of the company under the title of "comprehensively promoting the Great Rejuvenation of the Chinese Nation with Chinese Modernization" to interpret and preach the spirit of the 20th CPC National Congress.
2022
12-04